In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

the global biotechnology market is expected to experience substantial growth. This report outlines key findings and emerging trends in the biotechnology market, offering insight into the factors that ...

Q4 2024 Earnings Call Transcript February 19, 2025 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.64, expectations were $0.54. Operator: Ladies and gentlemen, thank you ...

The Biotechnology Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. biotechnology market size was worth at ...

Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...

Amicus Therapeutics has two products in the market that generated more than $528 million in revenue last year.

Both Smallcap and Microcap indices have formed bullish engulfing candlestick patterns on the daily chart, indicating a ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

Biotechnology stocks are among the most volatile in the market due to their high risk. The outcomes of FDA clinical trials and the effectiveness of their therapies in the real world might cause ...